TABLE 3.
Condition | Peak density | Activation | Kact | Steady‐state Inactivation | Kinact | Tau (τ) |
---|---|---|---|---|---|---|
pA/pF | mV | mV | mV | mV | ms | |
GFP (DMSO) | −58.6 ± 13.9 (15) | −21.8 ± 1.3 (12) | 4.3 ± 0.2 (12) | −58.9 ± 0.8 (14) | 5.8 ± 0.4 (14) | 1.0 ± 0.08 (15) |
GFP (FLPK) | −80.8 ± 12.2 (14) | −20.5 ± 1.2 (12) | 3.9 ± 0.3 (12) | −59.3 ± 1.9 (10) | 6.1 ± 0.5 (10) | 0.8 ± 0.03 (12)r |
FGF14‐GFP (DMSO) | −16.8 ± 3.3 (19) a,b | −16.6 ± 1.0 (10) d , e | 5.7 ± 0.4 (10) f,g | −54.9 ± 1.1 (8) j | 5.9 ± 0.9 (8) | 1.7 ± 0.4 (10) k |
FGF14‐GFP (FLPK) | −49.6 ± 7.2 (21) c | −20.8 ± 1.5 (11) | 5.7 ± 0.5 (11) h,i | −59.2 ± 2.1 (11) | 5.9 ± 0.6 (14) | 1.3 ± 0.2 (11) |
ΔNT‐FGF14‐GFP (DMSO) | –108 ± 18.4 (17) n | –21.2 ± 0.36 (14) | 4.61 ± 0.3 (14) | –70.2 ± 0.53 (13) o,p,q | 6.4 ± 0.44 (13) | 1.091 ± 0.07 (15) |
ΔNT‐FGF14‐GFP (FLPK) | −126.04 ± 12.3 (11) m , NS | –37.43 ± 0.3 (11) l , o,p,q | 1.63 ± 0.23 (11) | –68.3 ± 0.34 (11) o,p,q | 6.75 ± 0.32 (11) | 1.137 ± 0.08 (11) |
Data are mean ± SEM.
p < .001, one‐way ANOVA, post hoc Dunn test compared with GFP (DMSO) and (FLPK).
p < .05, unpaired t tests compared to FGF14‐GFP (DMSO).
p < .01, one‐way ANOVA, post hoc Fisher's LSD compared with GFP (DMSO).
p < .05, one‐way ANOVA, post hoc Fisher's LSD compared with GFP (FLPK).
p < .01, one‐way ANOVA, post hoc Fisher's LSD compared with GFP (DMSO) and (FLPK).
p < .01, one‐way ANOVA, post hoc Fisher's LSD compared with GFP (DMSO) and (FLPK).
p < .05, unpaired t tests compared to GFP (DMSO).
p < .05, one‐way ANOVA, post hoc Dunn test compared with GFP (DMSO).
p < .001, unpaired t tests compared to FGF14‐ΔNT‐GFP (DMSO).
p < .001, unpaired t tests compared to Nav1.6‐GFP (DMSO).
p < .05, unpaired t tests compared to Nav1.6‐GFP (DMSO).
p < .001, unpaired t tests compared to Nav1.6‐GFP (DMSO).
p = .0495, unpaired t tests compared to Nav1.6‐GFP (DMSO).
p < .5, unpaired t tests compared to FGF14‐ΔNT‐GFP (DMSO).